66 related articles for article (PubMed ID: 27128543)
1. Glycemic variability is an important risk factor for cardiovascular autonomic neuropathy in newly diagnosed type 2 diabetic patients.
Xu W; Zhu Y; Yang X; Deng H; Yan J; Lin S; Yang H; Chen H; Weng J
Int J Cardiol; 2016 Jul; 215():263-8. PubMed ID: 27128543
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study.
Jaiswal M; Divers J; Urbina EM; Dabelea D; Bell RA; Pettitt DJ; Imperatore G; Pihoker C; Dolan LM; Liese AD; Marcovina S; Linder B; Feldman EL; Pop-Busui R;
Pediatr Diabetes; 2018 Jun; 19(4):680-689. PubMed ID: 29292558
[TBL] [Abstract][Full Text] [Related]
3. Diabetic peripheral neuropathy and glycemic variability assessed by continuous glucose monitoring: A systematic review and meta-analysis.
Jia Y; Long D; Yang Y; Wang Q; Wu Q; Zhang Q
Diabetes Res Clin Pract; 2024 Jun; ():111757. PubMed ID: 38944250
[TBL] [Abstract][Full Text] [Related]
4. Increased glycemic variability results in abnormal differentiation of T cell subpopulation in type 2 diabetes patients.
Sun Q; Yang P; Gu QW; Gu WS; Wang W; Wang J; Mao XM
J Diabetes Complications; 2024 Jun; 38(6):108738. PubMed ID: 38643556
[TBL] [Abstract][Full Text] [Related]
5. Nerve conduction study of the association between glycemic variability and diabetes neuropathy.
Akaza M; Akaza I; Kanouchi T; Sasano T; Sumi Y; Yokota T
Diabetol Metab Syndr; 2018; 10():69. PubMed ID: 30214502
[TBL] [Abstract][Full Text] [Related]
6. Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial.
Tang Y; Shah H; Bueno Junior CR; Sun X; Mitri J; Sambataro M; Sambado L; Gerstein HC; Fonseca V; Doria A; Pop-Busui R
Diabetes Care; 2021 Jan; 44(1):164-173. PubMed ID: 33144354
[TBL] [Abstract][Full Text] [Related]
7. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?
Monnier L; Colette C; Owens DR
J Diabetes Sci Technol; 2008 Nov; 2(6):1094-100. PubMed ID: 19885298
[TBL] [Abstract][Full Text] [Related]
8. Decreased β-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes.
Yang X; Xu W; Zhu Y; Deng H; Tan Y; Zeng L; Weng J
Neurosci Bull; 2019 Feb; 35(1):25-33. PubMed ID: 30430334
[TBL] [Abstract][Full Text] [Related]
9. [Impacts of glycemic variability on the relationship between time in range and estimated glycated hemoglobin in patients with type 1 diabetes mellitus].
Peng HM; Deng HR; Zhou YW; Wang CF; Lyu J; Mai XD; Yang DZ; Lu J; Xu W; Yan JH
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(16):1190-1195. PubMed ID: 35462500
[No Abstract] [Full Text] [Related]
10. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Battelino T; Danne T; Bergenstal RM; Amiel SA; Beck R; Biester T; Bosi E; Buckingham BA; Cefalu WT; Close KL; Cobelli C; Dassau E; DeVries JH; Donaghue KC; Dovc K; Doyle FJ; Garg S; Grunberger G; Heller S; Heinemann L; Hirsch IB; Hovorka R; Jia W; Kordonouri O; Kovatchev B; Kowalski A; Laffel L; Levine B; Mayorov A; Mathieu C; Murphy HR; Nimri R; Nørgaard K; Parkin CG; Renard E; Rodbard D; Saboo B; Schatz D; Stoner K; Urakami T; Weinzimer SA; Phillip M
Diabetes Care; 2019 Aug; 42(8):1593-1603. PubMed ID: 31177185
[TBL] [Abstract][Full Text] [Related]
11. Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complications.
Zhang L; Sun XX; Tian QS
Acta Diabetol; 2024 Jun; 61(6):679-692. PubMed ID: 38467807
[TBL] [Abstract][Full Text] [Related]
12. Dysglycemia and arrhythmias.
Sun DK; Zhang N; Liu Y; Qiu JC; Tse G; Li GP; Roever L; Liu T
World J Diabetes; 2023 Aug; 14(8):1163-1177. PubMed ID: 37664481
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-protein vs. high-fat snacks before lunch on glycemic variability in prediabetes: A study protocol for a randomized controlled trial.
Liu Y; Jiang H; Ruan B; Liu Y; Le S; Fu X; Wang S
Front Nutr; 2022; 9():925870. PubMed ID: 35928840
[TBL] [Abstract][Full Text] [Related]
14. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
Yapanis M; James S; Craig ME; O'Neal D; Ekinci EI
J Clin Endocrinol Metab; 2022 May; 107(6):e2221-e2236. PubMed ID: 35094087
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive exploration of Cardiac Autonomic Neuropathy by heart rate and blood pressure variability analysis in Type 2 Diabetic patients.
Naz T; Memon NUN; Afzal K; Shakir A
Pak J Med Sci; 2021; 37(4):1020-1024. PubMed ID: 34290776
[TBL] [Abstract][Full Text] [Related]
16. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring.
Jackson MA; Ahmann A; Shah VN
Diabetes Technol Ther; 2021 Mar; 23(S1):S27-S34. PubMed ID: 33534631
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance is independently associated with cardiovascular autonomic neuropathy in type 2 diabetes.
Liu Y; Peng Y; Jin J; Chen Y; Chen C; Chen Z; Huang H; Xu L
J Diabetes Investig; 2021 Sep; 12(9):1651-1662. PubMed ID: 33460512
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]